HEALTH CARE BRIEFING: Medication talks continue as Pelosi presses vote

House tenant Nancy Pelosi (D-Calif.) Aims to push forward plans to vote this week on the two bills that make up President Joe Biden’s economic platform despite moderates echoing the senator. Joe manchin’s (DW.Va.) complains that they do not know the total cost and the economic impact.

None of the centrist Democrats have yet threatened to block a vote on a $ 1.75 trillion tax and spending plan that makes up the bulk of Biden’s agenda. Yet, it was another indication that Pelosi, Biden and other Democratic leaders had not completely sealed the deal to push through the measure.

Pelosi focuses on House vote on tax and spending proposal and separate $ 550 billion public works measure before attending UN climate summit in Glasgow as budget chair Jean Yarmut (D-Ky.) Said yesterday. Pelosi’s office has not announced when she will travel to the summit, which will last until November 12.

“We are on the way to passing our bill,” Pelosi said last night of the larger package, which includes climate and social spending paid for by tax increases. Pelosi is trying to strike a last-minute deal on drug price cuts to add to the measure to allow for a vote this week.

Senate Finance President Ron Wyden (D-Ore.) Said lawmakers have moved forward in negotiations to limit drug price increases and allow Medicare to negotiate certain prices, reports Steven T. Dennis. Democrats are still working on drugs that would be the subject of price negotiations, but insulin products could be the subject of negotiations as part of Part D. Learn more about Erik Wasson and Emily Wilkins.

The group is targeting Sinema: Patients For Affordable Drugs Now launched an advertisement in Arizona aimed at Sen. Kyrsten sinama (D-Arizona) to push for the inclusion of provisions allowing Medicare to negotiate lower drug prices in the package, the advocacy group said in a statement. The announcement will air on Arizona cable and digital television platforms starting this week.

The coronavirus pandemic

The rule on vaccines or workplace testing clarifies the White House review: Federal Covid-19 vaccination and testing mandate for employers with 100 or more employees set to be released after the White House regulatory office completes a three-week review of the emergency rule from OSHA. Analysis by the Office of Information and Regulatory Affairs is usually the last formal step before a final rule becomes public. In a notice released yesterday, the regulator said it has completed its review.

In an e-mailed statement yesterday, a spokesperson for the Department of Labor said the temporary emergency standard would be published in the Federal Register “within the next few days.” The standard will require covered employers to “develop, implement and enforce a mandatory Covid-19 vaccination policy, unless they adopt a policy requiring employees to choose either to be vaccinated or to undergo regular Covid-19 tests and wear a face cover at work. . “Read more from Bruce Rolfsen.

Finalization of the mandate on vaccines for healthcare workers: An interim final rule requiring Covid-19 vaccination for healthcare workers at facilities paid for by Medicare and Medicaid has cleared the White House review and can now be released at any time. The healthcare sector has led the charge for workplace immunization mandates, with many hospitals and healthcare systems demanding the blow for their staff ahead of state and federal mandates. The rule will come into effect upon posting to the Federal Register. Allie Reed has more.

Millions of children’s Covid vaccines shipped before CDC clearance: An estimated 15 million doses of children’s vaccines will arrive at thousands of sites across the country over the next week, as the White House prepares for widespread immunizations if the CDC approves. The Food and Drug Administration’s approval on Friday of the Pfizer vaccine for children aged 5 to 11 was a “critical operational milestone” that made it possible to ship the vaccines, said Jeff Zients, chief of Biden Covid-19. Josh Wingrove and Jeannie Baumann have more.

WHO calls for more experts to study the origins: The World Health Organization has reopened an expert search to join a committee to study the origins of the coronavirus to add more specialists in areas such as biosafety. Applicants have until tomorrow to express interest, and the WHO said yesterday it was looking for experts in social sciences, anthropology, ethics, political science and biosafety. The WHO’s proposal for 26 experts to conduct an investigation comes after an earlier offer was engulfed in controversy. Thomas Mulier has more.

More titles:

What else to know today

Four key moments in the Supreme Court’s abortion law arguments: The Supreme Court heard arguments yesterday over Texas’ new abortion law, which has halted most proceedings in the state, and the questioning offers some clues as to the outcome. Four of the judges were already inclined to suspend the law, which bans almost all abortions after about six weeks of pregnancy, months earlier than the High Court’s precedent. Justices Stephen Breyer, Elena Kagan and Sonia Sotomayor and Chief Justice John Roberts had all said they would have done so when abortion providers asked the court to suspend the law before it went into effect on September 1.

The other five believed it was too early for the court to intervene at this point. But now that he examines the matter in depth, some of those judges have signaled that they could be on the line. Kimberly Robinson offers four important moments from inside the courtroom.

J&J and Teva Defeat $ 50 Billion Opioid Case in First Industry Victory: Johnson & Johnson, Teva Pharmaceutical Industries and other former opioid makers won the pharmaceutical industry’s first victory in the sprawling four-year drug litigation, defeating a lawsuit filed by local governments in California that claimed to have created a public health crisis through deceptive marketing. .

Superior Court Judge Peter Wilson in Santa Ana yesterday dismissed allegations that units at J&J, Teva, Endo International and Abbvie’s Allergan deceived doctors and patients about opioid pain reliever addiction and created self-sufficiency. saying “public nuisance” related to drugs. Officials in Los Angeles, Santa Clara and Orange counties and the City of Oakland have asked for up to $ 50 billion to bolster law enforcement and treatment budgets depleted by the outbreak. Read more from Jef Feeley.

More titles:

To contact the reporter on this story: Brandon lee in Washington at [email protected]

To contact the editors responsible for this story: Zachary Sherwood To [email protected]; Giuseppe Macri To [email protected]; Michaela ross To [email protected]

Source link

About Jefferey G. Cannon

Check Also

REPEAT – MEDIA ADVISORY – Ford government plans to license tens of thousands of new long-term care bed licenses over 30 years to for-profit companies: new report to be released across Ontario with information local and provincial

TORONTO, Nov. 29, 2021 (GLOBE NEWSWIRE) – Over the past year, the Ford government implemented …